Literature DB >> 29037357

Topical timolol promotes healing of chronic leg ulcer.

Bindhiya Thomas1, John Sajan Kurien1, Toney Jose2, Sansho Elavumkal Ulahannan1, Sandeep Abraham Varghese1.   

Abstract

BACKGROUND: Chronic ulcers are a common problem, with chronic diabetic and venous ulcers forming a large proportion. This is the first case-control study to assess the effect of topical timolol on healing of chronic venous and chronic diabetic ulcers.
METHODS: The study included 60 patients with chronic leg ulcers. The ulcers in the study group (n = 30) were treated with topical 0.5% timolol maleate solution along with antibiotics and dressings; those in the control group (n = 30) received only antibiotics and dressings. The ulcers in both groups were evaluated at 4, 8, and 12 weeks, and ulcer area was calculated. Healing rate was assessed by calculating the percentage change in ulcer area.
RESULTS: The mean percentage change in area at 4, 8, and 12 weeks was 25.29, 43.77, and 61.79 in the study group and 11.92, 22.40, and 29.62 in the control group. Analysis showed that there were significant differences in percentage change in ulcer of the study and control groups at all three time points and also within the groups. The type of ulcer, history of alcohol consumption, and smoking did not affect the healing rates in the study group.
CONCLUSIONS: Topical β-blockade using timolol improves the healing of chronic leg ulcers.
Copyright © 2017 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29037357     DOI: 10.1016/j.jvsv.2017.04.019

Source DB:  PubMed          Journal:  J Vasc Surg Venous Lymphat Disord


  10 in total

1.  Absorption and Safety of Topically Applied Timolol for Treatment of Chronic Cutaneous Wounds.

Authors:  Anthony Cole Gallegos; Michael James Davis; Catherine N Tchanque-Fossuo; Kaitlyn West; Angela Eisentrout-Melton; Thomas R Peavy; Roy W Dixon; Roma P Patel; Sara Evona Dahle; Roslyn Rivkah Isseroff
Journal:  Adv Wound Care (New Rochelle)       Date:  2019-10-16       Impact factor: 4.730

2.  Effects of topical timolol for the prevention of radiation-induced dermatitis in breast cancer: a pilot triple-blind, placebo-controlled trial.

Authors:  Mohsen Nabi-Meybodi; Adeleh Sahebnasagh; Zahra Hakimi; Masoud Shabani; Ali Asghar Shakeri; Fatemeh Saghafi
Journal:  BMC Cancer       Date:  2022-10-20       Impact factor: 4.638

3.  The Beta 2 Adrenergic Receptor Antagonist Timolol Improves Healing of Combined Burn and Radiation Wounds.

Authors:  Huguette Albrecht; Hsin-Ya Yang; Maija Kiuru; Saipiroon Maksaereekul; Blythe Durbin-Johnson; Michael S Wong; Thomas R Stevenson; David M Rocke; R Rivkah Isseroff
Journal:  Radiat Res       Date:  2018-01-26       Impact factor: 2.841

Review 4.  Repurposing Ophthalmologic Timolol for Dermatologic Use: Caveats and Historical Review of Adverse Events.

Authors:  Daniel J Yoon; Ramanjot Kaur; Anthony Gallegos; Kaitlyn West; Hsinya Yang; Saul Schaefer; Catherine Tchanque-Fossuo; Sara E Dahle; R Rivkah Isseroff
Journal:  Am J Clin Dermatol       Date:  2020-11-25       Impact factor: 7.403

Review 5.  [Mechanisms of adrenergic β-antagonist for wounds and its application prospect in diabetic foot ulcers].

Authors:  Shiyi Sun; Jing Ma; Xingwu Ran
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2020-12-15

Review 6.  Strategies and challenges in the treatment of chronic venous leg ulcers.

Authors:  Shi-Yan Ren; Yong-Sheng Liu; Guo-Jian Zhu; Meng Liu; Shao-Hui Shi; Xiao-Dong Ren; Ya-Guang Hao; Rong-Ding Gao
Journal:  World J Clin Cases       Date:  2020-11-06       Impact factor: 1.337

7.  Efficacy and Safety of 0.25% Timolol Gel in Healing Split-Thickness Skin Graft Site.

Authors:  Amirhossein Ghanbarzamani; Ebrahim Salehifar; Abdolreza Jafarirad; Mohammad Hossein Hesamirostami; Ali Bagherzadehsaba; Majid Saeedi; Monireh Ghazaeian; Ghasemali Khorasani; Mahmood Moosazadeh
Journal:  Iran J Pharm Res       Date:  2021       Impact factor: 1.696

8.  Caged-carvedilol as a new tool for visible-light photopharmacology of β-adrenoceptors in native tissues.

Authors:  Anna Duran-Corbera; Joan Font; Melissa Faria; Eva Prats; Marta Consegal; Juanlo Catena; Lourdes Muñoz; Demetrio Raldua; Antonio Rodriguez-Sinovas; Amadeu Llebaria; Xavier Rovira
Journal:  iScience       Date:  2022-09-13

9.  Alpha and beta adrenergic receptors modulate keratinocyte migration.

Authors:  Hsin-Ya Yang; Pieter Steenhuis; Aaron M Glucksman; Zhanna Gurenko; Thi Dinh La; R Rivkah Isseroff
Journal:  PLoS One       Date:  2021-07-02       Impact factor: 3.240

Review 10.  Topical beta-blockers in dermatologic therapy.

Authors:  Angela Filoni; Francesca Ambrogio; Aurora De Marco; Alessia Pacifico; Domenico Bonamonte
Journal:  Dermatol Ther       Date:  2021-06-21       Impact factor: 2.851

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.